Table 3:
Open in new tab

Patient characteristics of the winter and summer surgery groups

November–March surgery (n = 34)April–October surgery (n = 64)P
Male gender, n (%)20 (59)35 (55)0.831
Age at TCPC (years)4.4 ± 2.05.1 ± 2.80.214
Weight at TCPC (kg)17.0 ± 6.319.0 ± 8.70.202
Weight-for-age Z score−0.44 ± 1.28−0.20 ± 2.190.567
Height at TCPC (cm)102 ± 15106 ± 180.169
Body mass index16.1 ± 2.216.2 ± 3.20.717
Right ventricular morphology, n (%)20 (59)29 (45)0.288
Heterotaxy, n (%)2 (6)7 (11)0.490
Hypoplastic left heart syndrome, n (%)11 (32)15 (23)0.348
Fenestration present, n (%)14 (41)19 (30)0.269
Previous pulmonary artery band, n (%)8 (23)16 (25)0.988
Superior vena cava (mmHg)12.2 ± 2.612.0 ± 3.10.779
Pre-TCPC O2 saturation (%)81 ± 781 ± 70.694
Ventricular function, n (%)
 Normal19 (56)45 (70)0.159
 Mildly impaired11 (32)17 (27)
 Moderately impaired4 (12)2 (3)
Atrioventricular valve regurgitation, n (%)
 No8 (23)21 (33)0.351
 Mild19 (56)36 (56)
 Moderate7 (21)7 (11)
Pulmonary artery branch stenosis, n (%)8 (24)12 (19)0.605
Systemic to pulmonary collateral flow (%)28.5 ± 7.423.3 ± 10.40.130
Leucocyte count, n8600 (6910–9610)7445 (5985–9395)0.152
Neutrophils as % of leucocytes60.7 (50.4–64.8)54.9 (45.9–61.7)0.066
Cardiopulmonary bypass time (min)79 ± 2872 ± 380.350
November–March surgery (n = 34)April–October surgery (n = 64)P
Male gender, n (%)20 (59)35 (55)0.831
Age at TCPC (years)4.4 ± 2.05.1 ± 2.80.214
Weight at TCPC (kg)17.0 ± 6.319.0 ± 8.70.202
Weight-for-age Z score−0.44 ± 1.28−0.20 ± 2.190.567
Height at TCPC (cm)102 ± 15106 ± 180.169
Body mass index16.1 ± 2.216.2 ± 3.20.717
Right ventricular morphology, n (%)20 (59)29 (45)0.288
Heterotaxy, n (%)2 (6)7 (11)0.490
Hypoplastic left heart syndrome, n (%)11 (32)15 (23)0.348
Fenestration present, n (%)14 (41)19 (30)0.269
Previous pulmonary artery band, n (%)8 (23)16 (25)0.988
Superior vena cava (mmHg)12.2 ± 2.612.0 ± 3.10.779
Pre-TCPC O2 saturation (%)81 ± 781 ± 70.694
Ventricular function, n (%)
 Normal19 (56)45 (70)0.159
 Mildly impaired11 (32)17 (27)
 Moderately impaired4 (12)2 (3)
Atrioventricular valve regurgitation, n (%)
 No8 (23)21 (33)0.351
 Mild19 (56)36 (56)
 Moderate7 (21)7 (11)
Pulmonary artery branch stenosis, n (%)8 (24)12 (19)0.605
Systemic to pulmonary collateral flow (%)28.5 ± 7.423.3 ± 10.40.130
Leucocyte count, n8600 (6910–9610)7445 (5985–9395)0.152
Neutrophils as % of leucocytes60.7 (50.4–64.8)54.9 (45.9–61.7)0.066
Cardiopulmonary bypass time (min)79 ± 2872 ± 380.350

HLHS: hypoplastic left heart syndrome; TCPC: total cavopulmonary connection.

Table 3:
Open in new tab

Patient characteristics of the winter and summer surgery groups

November–March surgery (n = 34)April–October surgery (n = 64)P
Male gender, n (%)20 (59)35 (55)0.831
Age at TCPC (years)4.4 ± 2.05.1 ± 2.80.214
Weight at TCPC (kg)17.0 ± 6.319.0 ± 8.70.202
Weight-for-age Z score−0.44 ± 1.28−0.20 ± 2.190.567
Height at TCPC (cm)102 ± 15106 ± 180.169
Body mass index16.1 ± 2.216.2 ± 3.20.717
Right ventricular morphology, n (%)20 (59)29 (45)0.288
Heterotaxy, n (%)2 (6)7 (11)0.490
Hypoplastic left heart syndrome, n (%)11 (32)15 (23)0.348
Fenestration present, n (%)14 (41)19 (30)0.269
Previous pulmonary artery band, n (%)8 (23)16 (25)0.988
Superior vena cava (mmHg)12.2 ± 2.612.0 ± 3.10.779
Pre-TCPC O2 saturation (%)81 ± 781 ± 70.694
Ventricular function, n (%)
 Normal19 (56)45 (70)0.159
 Mildly impaired11 (32)17 (27)
 Moderately impaired4 (12)2 (3)
Atrioventricular valve regurgitation, n (%)
 No8 (23)21 (33)0.351
 Mild19 (56)36 (56)
 Moderate7 (21)7 (11)
Pulmonary artery branch stenosis, n (%)8 (24)12 (19)0.605
Systemic to pulmonary collateral flow (%)28.5 ± 7.423.3 ± 10.40.130
Leucocyte count, n8600 (6910–9610)7445 (5985–9395)0.152
Neutrophils as % of leucocytes60.7 (50.4–64.8)54.9 (45.9–61.7)0.066
Cardiopulmonary bypass time (min)79 ± 2872 ± 380.350
November–March surgery (n = 34)April–October surgery (n = 64)P
Male gender, n (%)20 (59)35 (55)0.831
Age at TCPC (years)4.4 ± 2.05.1 ± 2.80.214
Weight at TCPC (kg)17.0 ± 6.319.0 ± 8.70.202
Weight-for-age Z score−0.44 ± 1.28−0.20 ± 2.190.567
Height at TCPC (cm)102 ± 15106 ± 180.169
Body mass index16.1 ± 2.216.2 ± 3.20.717
Right ventricular morphology, n (%)20 (59)29 (45)0.288
Heterotaxy, n (%)2 (6)7 (11)0.490
Hypoplastic left heart syndrome, n (%)11 (32)15 (23)0.348
Fenestration present, n (%)14 (41)19 (30)0.269
Previous pulmonary artery band, n (%)8 (23)16 (25)0.988
Superior vena cava (mmHg)12.2 ± 2.612.0 ± 3.10.779
Pre-TCPC O2 saturation (%)81 ± 781 ± 70.694
Ventricular function, n (%)
 Normal19 (56)45 (70)0.159
 Mildly impaired11 (32)17 (27)
 Moderately impaired4 (12)2 (3)
Atrioventricular valve regurgitation, n (%)
 No8 (23)21 (33)0.351
 Mild19 (56)36 (56)
 Moderate7 (21)7 (11)
Pulmonary artery branch stenosis, n (%)8 (24)12 (19)0.605
Systemic to pulmonary collateral flow (%)28.5 ± 7.423.3 ± 10.40.130
Leucocyte count, n8600 (6910–9610)7445 (5985–9395)0.152
Neutrophils as % of leucocytes60.7 (50.4–64.8)54.9 (45.9–61.7)0.066
Cardiopulmonary bypass time (min)79 ± 2872 ± 380.350

HLHS: hypoplastic left heart syndrome; TCPC: total cavopulmonary connection.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close